Special Studies and Analysis
| Lead Investigator | Topic | Status | |
|---|---|---|---|
|
2017 |
|||
| Lee J. Koh, M.D. |
Does induction treatment affect recurrent idiopathic FSGS onset and graft survival? |
Presented | |
| Sarah Twichwell, M.D. |
Longitudinal Assessment of Blood Transfusion Use in Pediatric Dialysis |
In Progress | |
|
2016 |
|||
| Isa Ashoor, M.D. |
Reassessing thymoglobulin induction in kidney transplantation (RETHINK): An analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry |
Completed | |
|
2008 |
|||
| Ashton Chen, D.O |
Effect of allograft failure on peritoneal and hemodialysis outcomes in pediatric population |
Published | |
| Susan Halbach, M.D. |
Hypertension in children on dialysis |
Published | |
| Karen McNeice, M.D. |
Effect of Blood Pressure Control on Progression of Chronic Kidney Disease |
Completed | |
Please find additional research initiatives here
Prospective Clinical Trials
|
2017 – |
Prospective Cohort Study to Describe Practice Patterns and Outcomes in Pediatric Patients (Chronic Kidney Disease, Dialysis and Transplant) with Cystinosis |
|
2017 – |
Single Arm, Multi-Center Study to Ascertain the Optimal Starting Dose of MIRCERA® Given Subcutaneously for the Maintenance Treatment of Anemia in Pediatric Patients with Chronic Kidney Disease on Dialysis or Not Yet on Dialysis |
|
2016 – |
A Phase 2, Open-Label, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer for Oral Suspension in Children and Adolescents 2 to < 18 Years of Age with Chronic Kidney Disease and Hyperkalemia |
|
2015 – |
Practice Patterns and Outcomes of Acthar Use in Children with Nephrotic Syndrome |
|
2015 – 2017 |
A Multicenter Single-Arm Extension Study to Characterize the Long-term Safety of Cinacalcet Hydrochloride in the Treatment of Secondary Hyperparathyroidism in Pediatric Subjects With Chronic Kidney Disease on Dialysis |
|
2015 – 2016 |
Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Via Dialysate and IV to Pediatric Patients on Chronic Hemodialysis |
Please find a complete listing of sponspored prospective clinical trails here